Form 8-K · Current report
Synchrony Financial 8-K, filed Jul 31, 2026
- Filed
- CIK
- 0001601712
- Accession no.
- 0001193125-26-328719
Summary
Synchrony Financial agreed on July 28, 2026 to sell $600 million of 5.450% fixed-to-floating rate senior notes due 2030 and $500 million of 6.276% fixed-to-floating rate senior notes due 2037 in a public offering, with J.P. Morgan Securities, TD Securities (USA) and Wells Fargo Securities acting as representatives of the underwriters.
Key points
- The underwriting agreement was entered into on July 28, 2026, with J.P. Morgan Securities LLC, TD Securities (USA) LLC and Wells Fargo Securities, LLC as representatives of the several underwriters.
- The notes are governed by an indenture between Synchrony Financial and The Bank of New York Mellon as trustee, as supplemented by a Sixteenth Supplemental Indenture dated July 31, 2026.
- The offering is made under Synchrony Financial's existing shelf registration statement on Form S-3.
- Sidley Austin LLP provided an opinion on the validity of the notes.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events On July 28, 2026, Synchrony Financial (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, TD Securities (USA) LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters listed on Schedule I to the Underwriting Agreement (collectively, the “Underwriters”), to issue and sell $600,000,000 aggregate principal amount of 5.450% Fixed-to-Floating Rate Senior Notes due 2030 (the “2030 Notes”) and $500,000,000 aggregate principal amount of 6.276% Fixed-to-Floating Rate Senior Notes due 2037 (the “2037 Notes” and, together with the 2030 Notes, the “Notes”) in a public offering pursuant…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.